Neil Kumar
2019 - BridgeBio Pharma
In 2019, Neil Kumar earned a total compensation of $26.3M as Chief Executive Officer at BridgeBio Pharma, a 5,752% increase compared to previous year.
Compensation breakdown
| Bonus | $360,000 |
|---|---|
| Option Awards | $11,573,049 |
| Salary | $502,765 |
| Stock Awards | $13,863,445 |
| Other | $34,804 |
| Total | $26,334,063 |
Kumar received $13.9M in stock awards, accounting for 53% of the total pay in 2019.
Kumar also received $360K in bonus, $11.6M in option awards, $502.8K in salary and $34.8K in other compensation.
Rankings
In 2019, Neil Kumar's compensation ranked 70th out of 13,971 executives tracked by ExecPay. In other words, Kumar earned more than 99.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 70 out of 13,971 | 100th |
Division Manufacturing | 21 out of 5,701 | 100th |
Major group Chemicals And Allied Products | 5 out of 2,200 | 100th |
Industry group Drugs | 5 out of 1,886 | 100th |
Industry Pharmaceutical Preparations | 4 out of 1,398 | 100th |
Source: SEC filing on April 22, 2020.
Kumar's colleagues
We found two more compensation records of executives who worked with Neil Kumar at BridgeBio Pharma in 2019.